Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check5 days agoChange DetectedRemoved the 'Rheumatoid arthritis' condition label and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, representing a metadata/version update that does not affect the study information or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a Show glossary option and updated metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. No substantive changes to the study content are visible.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics to the page's related topics. This does not modify study information or page functionality.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.